DSpace@İnönü

Yazar "Iannone, F" için listeleme

Yazar "Iannone, F" için listeleme

Sırala: Sıra: Sonuçlar:

  • Effectiveness and treatment retention of TNF inhibitors when used as 
    Lindstrom, U; Di Giuseppe, D; Delcoigne, B; Glintborg, B; Moller, B; Ciurea, A; Pombo-Suarez, M; Sanchez-Piedra, C; Eklund, K; Relas, H; Gudbjornsson, B; Love, TJ; Jones, GT; Codreanu, C; Ionescu, R; Nekvindova, L; Zavada, J; Atas, N; Yolbas, S; Fagerli, KM; Michelsen, B; Rotar, Z; Tomsic, M; Iannone, F; Santos, MJ; Avila-Ribeiro, P; Ornbjerg, LM; Ostergaard, M; Jacobsson, LTH; Askling, J; Nissen, MJ (2021)
    Background Comedication with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively used in psoriatic arthritis (PsA), although ...
  • Effectiveness and treatment retention of TNF inhibitors when used as 
    Lindstrom, U; Di Giuseppe, D; Delcoigne, B; Glintborg, B; Moller, B; Ciurea, A; Pombo-Suarez, M; Sanchez-Piedra, C; Eklund, K; Relas, H; Gudbjornsson, B; Love, TJ; Jones, GT; Codreanu, C; Ionescu, R; Nekvindova, L; Zavada, J; Atas, N; Yolbas, S; Fagerli, KM; Michelsen, B; Rotar, Z; Tomsic, M; Iannone, F; Santos, MJ; Avila-Ribeiro, P; Ornbjerg, LM; Ostergaard, M; Jacobsson, LTH; Askling, J; Nissen, MJ (2021)
    Background Comedication with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively used in psoriatic arthritis (PsA), although ...
  • Effectiveness and treatment retention of TNF inhibitors when used as 
    Lindstrom, U; Di Giuseppe, D; Delcoigne, B; Glintborg, B; Moller, B; Ciurea, A; Pombo-Suarez, M; Sanchez-Piedra, C; Eklund, K; Relas, H; Gudbjornsson, B; Love, TJ; Jones, GT; Codreanu, C; Ionescu, R; Nekvindova, L; Zavada, J; Atas, N; Yolbas, S; Fagerli, KM; Michelsen, B; Rotar, Z; Tomsic, M; Iannone, F; Santos, MJ; Avila-Ribeiro, P; Ornbjerg, LM; Ostergaard, M; Jacobsson, LTH; Askling, J; Nissen, MJ (2021)
    Background Comedication with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively used in psoriatic arthritis (PsA), although ...